Medical algorithm: Diagnosis and management of histaminergic angioedema
Abstract
No abstract availableKeywords
Funding Information
- Instituto de Salud Carlos III
This publication has 12 references indexed in Scilit:
- Assessment of disease activity and quality of life in patients with recurrent bradykinin-mediated versus mast cell-mediated angioedemaWorld Allergy Organization Journal, 2021
- A Comparative Study of Sex Distribution, Autoimmunity, Blood, and Inflammatory Parameters in Chronic Spontaneous Urticaria with Angioedema and Chronic Histaminergic AngioedemaThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- Development of the Angioedema Control Test—A patient‐reported outcome measure that assesses disease control in patients with recurrent angioedemaAllergy, 2019
- Angioedema MasqueradersClinical & Experimental Allergy, 2019
- Threshold‐stimulated kallikrein activity distinguishes bradykinin‐ from histamine‐mediated angioedemaClinical & Experimental Allergy, 2018
- Idiopathic Non-histaminergic Angioedema: Successful Treatment with Omalizumab in Five PatientsJournal of Clinical Immunology, 2016
- Positive response to omalizumab in patients with acquired idiopathic nonhistaminergic angioedemaAnnals of Allergy, Asthma & Immunology, 2015
- Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working GroupAllergy, 2014
- Development, validation, and initial results of the Angioedema Activity ScoreAllergy, 2013
- AngioedemaWorld Allergy Organization Journal, 2008